Search research articles
Contact Us
Filters
Showing results (451-460 of 474) with videos related to
Page
of 48
Sort By:
Molecular Cancer
|
June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Mareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2019
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L George, Elisa Izquierdo, James Campbell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer
Steven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
Nature Communications
|
August 5, 2025
Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function
Marta Barisa, Henrike P Muller, Elisa Zappa, et al.
British Journal of Cancer
|
July 9, 2026
Paediatric therapeutic development workshop on medulloblastoma
Claudia Montiel Equihua, Joseph S Baxter, Jan J Molenaar, et al.
JAMA
|
November 28, 2018
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial
Aleena Banerji, Marc A Riedl, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 18, 2019
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
Timothy Craig, Bruce Zuraw, Hilary Longhurst, et al.
Science Translational Medicine
|
November 26, 2020
Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastoma
Karin Straathof, Barry Flutter, Rebecca Wallace, et al.
The Lancet. Oncology
|
April 3, 2025
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Andrew D J Pearson, Claudia Rossig, Crystal L Mackall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2020
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
Andrew D J Pearson, Claudia Rossig, Giovanni Lesa, et al.
Page
of 48
Search research articles
Search
Showing results (451-460 of 474) with videos related to
Sort By:
Page
of 48
Molecular Cancer
|
June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Mareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2019
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L George, Elisa Izquierdo, James Campbell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer
Steven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
Nature Communications
|
August 5, 2025
Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function
Marta Barisa, Henrike P Muller, Elisa Zappa, et al.
British Journal of Cancer
|
July 9, 2026
Paediatric therapeutic development workshop on medulloblastoma
Claudia Montiel Equihua, Joseph S Baxter, Jan J Molenaar, et al.
JAMA
|
November 28, 2018
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial
Aleena Banerji, Marc A Riedl, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 18, 2019
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
Timothy Craig, Bruce Zuraw, Hilary Longhurst, et al.
Science Translational Medicine
|
November 26, 2020
Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastoma
Karin Straathof, Barry Flutter, Rebecca Wallace, et al.
The Lancet. Oncology
|
April 3, 2025
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Andrew D J Pearson, Claudia Rossig, Crystal L Mackall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2020
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
Andrew D J Pearson, Claudia Rossig, Giovanni Lesa, et al.
Page
of 48